Shatavari Ghrita preparation and Clinical trial in Allergic Conjunctivitis

Evaluate the effect of Shatavari Ghrita in Simple Allergic Conjunctivitis a randomised controlled clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096556

Enrollment

Registered

2025-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H109- Unspecified conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with signs and symptoms of Simple Allergic Conjunctivitis and fulfilling the diagnostic criteria Diagnostic Criteria Patient of simple allergic conjunctivitis with the established signs & symptoms of Itching Redness Oedema & Watering with eosinophilia will be subjected for detailed anterior segment examination using slit lamp biomicroscope for diagnosis

Exclusion criteria

Exclusion criteria: Subjects of other forms Allergic Conjunctivitis like Vernal keratoconjunctivitis Atopic keratoconjunctivitis Giant papillary Conjunctivitis drug or material sensitivity Subjects having severe conditions of ocular surface disorders Subjects having complicated eye diseases like Trachoma Trichiasis Steven Johnson Syndrome will be excluded Subject suffering from Bacterial Chlamydial Parasitic and all other types of Conjunctivitis (contagious & non contagious) Subjects suffering from Corneal Ulcers Opacities Trauma Foreign bodies Diagnosed cases of Conjunctival epitheliopathies like pterygium pseudo-pterygium Tumours Retention cysts Subjects having of Glaucoma Retinopathies Optic Neuritis and who are under long term topical ocular drug therapies for any Ophthalmic infective conditions Extremely debilitated subjects Pregnant ladies Lactating ladies those who are working with on screen professions Diagnosed cases of specific systemic disorders like Renal pathologies Uncontrolled Diabetes Uncontrolled Hypertension Hyperlipidemia Cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Shatavari Ghrita in Simple Allergic ConjunctivitisTimepoint: DAY 0th (Before Treatment) DAY 21 (After Treatment) DAY 36 (Follow Up)	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Arunkumar B Biradar

KAHER s Shri B M Kankanawadi Ayurveda Mahavidyalaya Hospital and Research Centre Shahpur

arunkumar.biradar@gmail.com9964064955

Outcome results